How should biomarkers for safety be identified and selected?

被引：0

|

作者：

Wärngärd, L ^{[1
]}

机构：

[1] VINNOVA, Dept Biotechnol, SE-10158 Stockholm, Sweden

来源：

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2004年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：S23 / S24

页数：2

相关论文

共 50 条

[31] Quality and safety at the point of care: how long should a ward round take?
Herring, Roselle
Desai, Tejal
Caldwell, Gordon
CLINICAL MEDICINE, 2011, 11 (01) : 20 - 22
[32] Jahniverse How the US government should step up to ensure orbital safety
Jah, Moriba
AEROSPACE AMERICA, 2022, 60 (10) : 61 - +
[33] How should anaesthetic skills best be deployed for quality, safety and efficiency of care?
Coldwell, C.
Craig, W.
ANAESTHESIA, 2023, 78 (03) : 279 - 281
[34] SHOULD YEASTS IN RESPIRATORY SECRETIONS BE IDENTIFIED
MURRAY, PR
VANSCOY, RE
ROBERTS, GD
MAYO CLINIC PROCEEDINGS, 1977, 52 (01) : 42 - 45
[35] Biomarkers of paraganglioma metastatic potential identified
Rosanne Diaz
Nature Reviews Endocrinology, 2011, 7 (7) : 375 - 375
[36] Possible biomarkers for preterm birth identified
Arnaud, Celia
CHEMICAL & ENGINEERING NEWS, 2019, 97 (10) : 8 - 8
[37] Potential biomarkers of suicide risk identified
Wilson, Hannah
BIOMARKERS IN MEDICINE, 2013, 7 (05) : 686 - 686
[38] KHK: New Biomarkers are identified for Inflammation
Franke, Katharina
AKTUELLE KARDIOLOGIE, 2018, 7 (05)
[39] Contrast-induced acute kidney injury: how should at-risk patients be identified and managed?
Laville, Maurice
Juillard, Laurent
JOURNAL OF NEPHROLOGY, 2010, 23 (04) : 387 - 398
[40] Pathologies currently identified by exhaled biomarkers
Mazzatenta, Andrea
Di Giulio, Camillo
Pokorski, Mieczyslaw
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY, 2013, 187 (01) : 128 - 134

← 1 2 3 4 5 →